Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B

Background PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant chang...

Full description

Saved in:
Bibliographic Details
Published inIndian journal of gastroenterology Vol. 32; no. 5; pp. 307 - 310
Main Authors Mogarekar, Mukund Ramchandra, Talekar, Swati Jitendra
Format Journal Article
LanguageEnglish
Published India Springer India 01.09.2013
Subjects
Online AccessGet full text
ISSN0254-8860
0975-0711
0975-0711
DOI10.1007/s12664-013-0334-1

Cover

Loading…
Abstract Background PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant changes in serum arylesterase (AE) and lactonase activities of PON. The second objective was to determine whether there was any correlation between serum AE and lactonase activities and the various routine liver function tests. The usefulness of adding serum lactonase and AE activity to standard liver function tests was analyzed by multiple logistic regression analysis. Finally, the diagnostic efficacy or analytical performance of AE and lactonase in assessing patients with CLD was determined using ‘receiver operating characteristic’ (ROC) plot. Methods The study group consisted of 120 subjects; 60 were patients with liver disease out of which 40 were having chronic alcoholic liver disease and 20, acute viral hepatitis B, and 60 were healthy controls. Serum PON1 lactonase activity was measured manually using dihydrocoumarin, and AE activity was measured using phenylacetate as substrate. Liver function tests (bilirubin, albumin, AST, ALT, alkaline phosphatise) were done by standard technique. Result The serum lactonase and AE activities were decreased significantly in patients with chronic alcoholic liver disease ( p  < 0.001, p  < 0.001) and acute viral hepatitis B ( p  < 0.001, p  < 0.001). Both measurements showed higher efficiency in testing liver dysfunction in multivariate regression analysis. Model 1 consisted of bilirubin, albumin, AST, ALT, and alkaline phosphatase, R2 = 0.912. Model 2 consisted of model 1+arylesterase having higher R2 = 0.0.954, and model 3 consisted of model 1+lactonase having R2 = 0.962. ROC plots demonstrated a high diagnostic accuracy for serum PON1 lactonase (area under ROC curve = 0.982) and serum PON1 arylesterase (area under ROC curve = 0.986). Conclusion Low PON1 lactonase and AE activity were found in acute viral hepatitis B and in chronic alcoholic hepatitis.
AbstractList Background PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant changes in serum arylesterase (AE) and lactonase activities of PON. The second objective was to determine whether there was any correlation between serum AE and lactonase activities and the various routine liver function tests. The usefulness of adding serum lactonase and AE activity to standard liver function tests was analyzed by multiple logistic regression analysis. Finally, the diagnostic efficacy or analytical performance of AE and lactonase in assessing patients with CLD was determined using ‘receiver operating characteristic’ (ROC) plot. Methods The study group consisted of 120 subjects; 60 were patients with liver disease out of which 40 were having chronic alcoholic liver disease and 20, acute viral hepatitis B, and 60 were healthy controls. Serum PON1 lactonase activity was measured manually using dihydrocoumarin, and AE activity was measured using phenylacetate as substrate. Liver function tests (bilirubin, albumin, AST, ALT, alkaline phosphatise) were done by standard technique. Result The serum lactonase and AE activities were decreased significantly in patients with chronic alcoholic liver disease ( p  < 0.001, p  < 0.001) and acute viral hepatitis B ( p  < 0.001, p  < 0.001). Both measurements showed higher efficiency in testing liver dysfunction in multivariate regression analysis. Model 1 consisted of bilirubin, albumin, AST, ALT, and alkaline phosphatase, R2 = 0.912. Model 2 consisted of model 1+arylesterase having higher R2 = 0.0.954, and model 3 consisted of model 1+lactonase having R2 = 0.962. ROC plots demonstrated a high diagnostic accuracy for serum PON1 lactonase (area under ROC curve = 0.982) and serum PON1 arylesterase (area under ROC curve = 0.986). Conclusion Low PON1 lactonase and AE activity were found in acute viral hepatitis B and in chronic alcoholic hepatitis.
PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant changes in serum arylesterase (AE) and lactonase activities of PON. The second objective was to determine whether there was any correlation between serum AE and lactonase activities and the various routine liver function tests. The usefulness of adding serum lactonase and AE activity to standard liver function tests was analyzed by multiple logistic regression analysis. Finally, the diagnostic efficacy or analytical performance of AE and lactonase in assessing patients with CLD was determined using 'receiver operating characteristic' (ROC) plot. The study group consisted of 120 subjects; 60 were patients with liver disease out of which 40 were having chronic alcoholic liver disease and 20, acute viral hepatitis B, and 60 were healthy controls. Serum PON1 lactonase activity was measured manually using dihydrocoumarin, and AE activity was measured using phenylacetate as substrate. Liver function tests (bilirubin, albumin, AST, ALT, alkaline phosphatise) were done by standard technique. The serum lactonase and AE activities were decreased significantly in patients with chronic alcoholic liver disease (p < 0.001, p < 0.001) and acute viral hepatitis B (p < 0.001, p < 0.001). Both measurements showed higher efficiency in testing liver dysfunction in multivariate regression analysis. Model 1 consisted of bilirubin, albumin, AST, ALT, and alkaline phosphatase, R2 = 0.912. Model 2 consisted of model 1+arylesterase having higher R2 = 0.0.954, and model 3 consisted of model 1+lactonase having R2 = 0.962. ROC plots demonstrated a high diagnostic accuracy for serum PON1 lactonase (area under ROC curve = 0.982) and serum PON1 arylesterase (area under ROC curve = 0.986). Low PON1 lactonase and AE activity were found in acute viral hepatitis B and in chronic alcoholic hepatitis.
PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant changes in serum arylesterase (AE) and lactonase activities of PON. The second objective was to determine whether there was any correlation between serum AE and lactonase activities and the various routine liver function tests. The usefulness of adding serum lactonase and AE activity to standard liver function tests was analyzed by multiple logistic regression analysis. Finally, the diagnostic efficacy or analytical performance of AE and lactonase in assessing patients with CLD was determined using 'receiver operating characteristic' (ROC) plot.BACKGROUNDPON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant changes in serum arylesterase (AE) and lactonase activities of PON. The second objective was to determine whether there was any correlation between serum AE and lactonase activities and the various routine liver function tests. The usefulness of adding serum lactonase and AE activity to standard liver function tests was analyzed by multiple logistic regression analysis. Finally, the diagnostic efficacy or analytical performance of AE and lactonase in assessing patients with CLD was determined using 'receiver operating characteristic' (ROC) plot.The study group consisted of 120 subjects; 60 were patients with liver disease out of which 40 were having chronic alcoholic liver disease and 20, acute viral hepatitis B, and 60 were healthy controls. Serum PON1 lactonase activity was measured manually using dihydrocoumarin, and AE activity was measured using phenylacetate as substrate. Liver function tests (bilirubin, albumin, AST, ALT, alkaline phosphatise) were done by standard technique.METHODSThe study group consisted of 120 subjects; 60 were patients with liver disease out of which 40 were having chronic alcoholic liver disease and 20, acute viral hepatitis B, and 60 were healthy controls. Serum PON1 lactonase activity was measured manually using dihydrocoumarin, and AE activity was measured using phenylacetate as substrate. Liver function tests (bilirubin, albumin, AST, ALT, alkaline phosphatise) were done by standard technique.The serum lactonase and AE activities were decreased significantly in patients with chronic alcoholic liver disease (p < 0.001, p < 0.001) and acute viral hepatitis B (p < 0.001, p < 0.001). Both measurements showed higher efficiency in testing liver dysfunction in multivariate regression analysis. Model 1 consisted of bilirubin, albumin, AST, ALT, and alkaline phosphatase, R2 = 0.912. Model 2 consisted of model 1+arylesterase having higher R2 = 0.0.954, and model 3 consisted of model 1+lactonase having R2 = 0.962. ROC plots demonstrated a high diagnostic accuracy for serum PON1 lactonase (area under ROC curve = 0.982) and serum PON1 arylesterase (area under ROC curve = 0.986).RESULTThe serum lactonase and AE activities were decreased significantly in patients with chronic alcoholic liver disease (p < 0.001, p < 0.001) and acute viral hepatitis B (p < 0.001, p < 0.001). Both measurements showed higher efficiency in testing liver dysfunction in multivariate regression analysis. Model 1 consisted of bilirubin, albumin, AST, ALT, and alkaline phosphatase, R2 = 0.912. Model 2 consisted of model 1+arylesterase having higher R2 = 0.0.954, and model 3 consisted of model 1+lactonase having R2 = 0.962. ROC plots demonstrated a high diagnostic accuracy for serum PON1 lactonase (area under ROC curve = 0.982) and serum PON1 arylesterase (area under ROC curve = 0.986).Low PON1 lactonase and AE activity were found in acute viral hepatitis B and in chronic alcoholic hepatitis.CONCLUSIONLow PON1 lactonase and AE activity were found in acute viral hepatitis B and in chronic alcoholic hepatitis.
Author Talekar, Swati Jitendra
Mogarekar, Mukund Ramchandra
Author_xml – sequence: 1
  givenname: Mukund Ramchandra
  surname: Mogarekar
  fullname: Mogarekar, Mukund Ramchandra
  email: mrmogarekar@hotmail.com
  organization: Department of Biochemistry, Swami Ramanand Teerth Rural Government Medical College
– sequence: 2
  givenname: Swati Jitendra
  surname: Talekar
  fullname: Talekar, Swati Jitendra
  organization: Department of Biochemistry, Swami Ramanand Teerth Rural Government Medical College
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23700138$$D View this record in MEDLINE/PubMed
BookMark eNp9kEtPAyEQx4nR2Id-AC9mj15WB1iW7lEbX0kTEx9nwtKppdlChV0Tv730oSYeemJm8v8B8xuQQ-cdEnJG4ZICyKtIWVkWOVCeA-dFTg9IHyopcpCUHqaaiSIfjUrokUGMC1j3FT8mPcYlJGrUJ88vGLpl1mjTeqcjZtpNMx2-Gowths3AtPbTthZjZl2mG-PnvrEmm-NKt2keN8hfd3NCjma6iXi6O4fk7e72dfyQT57uH8fXk9zwomhzUUMpNdamqpk0JRqtEZkQNZUUZCUlToUAjnTGRC0KYRgy5FVlDBiBU8OH5GJ77yr4jy79Vy1tNNg02qHvoqIFKwFKJiFFz3fRrl7iVK2CXaYl1Y-HFKDbgAk-xoCz3wgFtXattq5VSqu1a0UTI_8xxrZJgndt0LbZS7ItGdMr7h2DWvguuCRrD_QNgAyS5w
CitedBy_id crossref_primary_10_3390_vetsci10010033
crossref_primary_10_7759_cureus_46234
crossref_primary_10_1097_MD_0000000000002179
crossref_primary_10_1371_journal_pone_0149207
crossref_primary_10_1186_1746_6148_10_74
crossref_primary_10_1089_omi_2020_0160
crossref_primary_10_1080_01480545_2021_1986061
crossref_primary_10_1016_j_mgene_2013_09_007
crossref_primary_10_1139_bcb_2017_0216
crossref_primary_10_1515_tjb_2018_0156
crossref_primary_10_1016_j_cbi_2023_110563
crossref_primary_10_1017_S0007114515004985
Cites_doi 10.1006/geno.1996.0225
10.1096/fj.00-0650rev
10.1016/j.clinbiochem.2008.09.120
10.1016/S0891-5849(98)00272-X
10.1016/j.jhep.2005.12.018
10.1021/bi047440d
10.1002/jbt.20181
10.1172/JCI1649
10.1111/j.1742-1241.2006.01206..x
10.1007/978-1-4020-6561-3_12
10.4103/1319-3767.61232
10.1016/S0009-9120(99)00056-9
10.1007/978-1-4020-6561-3_1
10.1016/j.clinbiochem.2007.01.020
10.3748/wjg.v11.i46.7351
10.1016/S0022-2275(20)33445-3
10.1093/clinchem/48.2.261
10.1016/S0090-9556(24)15082-9
ContentType Journal Article
Copyright Indian Society of Gastroenterology 2013
Copyright_xml – notice: Indian Society of Gastroenterology 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1007/s12664-013-0334-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 0975-0711
EndPage 310
ExternalDocumentID 23700138
10_1007_s12664_013_0334_1
Genre Journal Article
GroupedDBID ---
-EM
06D
0R~
0VY
1N0
203
29I
29~
2CU
2KG
2VQ
2WC
30V
4.4
406
408
40D
53G
5GY
5VS
67Z
8TC
96X
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
AAZMS
ABAKF
ABDZT
ABECU
ABFTV
ABJNI
ABJOX
ABKCH
ABMQK
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABXPI
ACAOD
ACCUX
ACGFO
ACGFS
ACHSB
ACKNC
ACMDZ
ACMLO
ACOKC
ACPIV
ACREN
ACZOJ
ADBBV
ADHHG
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFQL
AEGNC
AEGXH
AEJHL
AEJRE
AEMSY
AEOHA
AEPYU
AESKC
AETCA
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AIAGR
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALFXC
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
ANMIH
AOCGG
AXYYD
BAWUL
BGNMA
C1A
CAG
COF
CSCUP
DDRTE
DIK
DNIVK
DPUIP
DU5
E3Z
EBLON
EBS
EIOEI
EJD
EN4
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FYJPI
GGCAI
GGRSB
GJIRD
GQ6
GQ7
GX1
H13
HF~
HG6
HMJXF
HRMNR
HZ~
I0C
IKXTQ
IWAJR
IXC
IXD
J-C
J0Z
JBSCW
JZLTJ
KOV
LLZTM
M4Y
MA-
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OK1
P2P
P9S
PT4
R9I
RLLFE
ROL
RSV
S1Z
S27
S37
S3B
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
T13
TR2
TSG
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W2D
W48
WK8
XSB
Z45
Z7U
Z87
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
OVT
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c344t-5b067aebc9b27c6ecaaee255b17107977ed5503e1f25b545c2e2e399cc0c5edc3
IEDL.DBID U2A
ISSN 0254-8860
0975-0711
IngestDate Tue Aug 05 11:19:12 EDT 2025
Wed Feb 19 01:56:03 EST 2025
Thu Apr 24 23:07:02 EDT 2025
Wed Aug 20 07:41:13 EDT 2025
Fri Feb 21 02:34:23 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Lactonase
Paraoxonase
Alcoholic liver disease
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c344t-5b067aebc9b27c6ecaaee255b17107977ed5503e1f25b545c2e2e399cc0c5edc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 23700138
PQID 1426006270
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_1426006270
pubmed_primary_23700138
crossref_primary_10_1007_s12664_013_0334_1
crossref_citationtrail_10_1007_s12664_013_0334_1
springer_journals_10_1007_s12664_013_0334_1
PublicationCentury 2000
PublicationDate 20130900
2013-9-00
2013-Sep
20130901
PublicationDateYYYYMMDD 2013-09-01
PublicationDate_xml – month: 9
  year: 2013
  text: 20130900
PublicationDecade 2010
PublicationPlace India
PublicationPlace_xml – name: India
PublicationTitle Indian journal of gastroenterology
PublicationTitleAbbrev Indian J Gastroenterol
PublicationTitleAlternate Indian J Gastroenterol
PublicationYear 2013
Publisher Springer India
Publisher_xml – name: Springer India
References Aviram, Rosenblat, Bisgauier, Newton, Primo-Parmo, La Du (CR3) 1998; 101
Billecke, Draganov, Counsell (CR8) 2000; 28
Killic, Aydin, Killic, Erman, Aydin, Celik (CR6) 2005; 11
Kujiraoka, Oka, Ishihara (CR13) 2000; 41
Ferre, Camps, Prats (CR4) 2002; 48
Kedage, Muttigi, Shetty (CR12) 2010; 16
Furlong (CR14) 2008
Aslan, Horoz, Nazligul (CR5) 2008; 62
Khersonsky, Tawfik (CR15) 2005; 44
Marsillach, Ferre, Vila (CR17) 2007; 40
Ferré, Marsillach, Camps (CR19) 2006; 45
Primo-Parmo, Sorenson, Teiber, La Du (CR2) 1996; 33
Tsukamoto, Lu (CR1) 2001; 15
Eckerson, Wyte, LA Du (CR9) 1983; 35
Marsillach, Aragones, Beltran (CR10) 2009; 42
Hill, Devarajan, Joshi-Barve, Barve, McClain (CR11) 1999; 32
Furlong (CR16) 2007; 21
Aviram, Rosenblat, Billecke (CR18) 1999; 26
Marsillach, Parra, Ferré (CR7) 2008
M Aviram (334_CR3) 1998; 101
J Marsillach (334_CR17) 2007; 40
SS Killic (334_CR6) 2005; 11
CE Furlong (334_CR14) 2008
S Billecke (334_CR8) 2000; 28
M Aviram (334_CR18) 1999; 26
M Aslan (334_CR5) 2008; 62
T Kujiraoka (334_CR13) 2000; 41
O Khersonsky (334_CR15) 2005; 44
J Marsillach (334_CR10) 2009; 42
J Marsillach (334_CR7) 2008
V Kedage (334_CR12) 2010; 16
DB Hill (334_CR11) 1999; 32
SL Primo-Parmo (334_CR2) 1996; 33
N Ferre (334_CR4) 2002; 48
H Tsukamoto (334_CR1) 2001; 15
HW Eckerson (334_CR9) 1983; 35
N Ferré (334_CR19) 2006; 45
CE Furlong (334_CR16) 2007; 21
17936934 - J Biochem Mol Toxicol. 2007;21(4):197-205
17887991 - Int J Clin Pract. 2008 Jul;62(7):1050-5
17335791 - Clin Biochem. 2007 Jun;40(9-10):645-50
10614719 - Clin Biochem. 1999 Oct;32(7):563-70
16437641 - World J Gastroenterol. 2005 Dec 14;11(46):7351-4
9541487 - J Clin Invest. 1998 Apr 15;101(8):1581-90
20339175 - Saudi J Gastroenterol. 2010 Apr-Jun;16(2):79-83
11038162 - Drug Metab Dispos. 2000 Nov;28(11):1335-42
11387231 - FASEB J. 2001 Jun;15(8):1335-49
10232833 - Free Radic Biol Med. 1999 Apr;26(7-8):892-904
10946025 - J Lipid Res. 2000 Aug;41(8):1358-63
15835926 - Biochemistry. 2005 Apr 26;44(16):6371-82
11805006 - Clin Chem. 2002 Feb;48(2):261-8
6316781 - Am J Hum Genet. 1983 Nov;35(6):1126-38
16510204 - J Hepatol. 2006 Jul;45(1):51-9
8661009 - Genomics. 1996 May 1;33(3):498-507
18977341 - Clin Biochem. 2009 Jan;42(1-2):91-8
References_xml – volume: 33
  start-page: 498
  year: 1996
  end-page: 507
  ident: CR2
  article-title: The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family
  publication-title: Genomics
  doi: 10.1006/geno.1996.0225
– volume: 11
  start-page: 7351
  year: 2005
  end-page: 7354
  ident: CR6
  article-title: Serum arylesterase and paraoxonase activity in patients with chronic hepatitis
  publication-title: World J Gastroenterol
– volume: 41
  start-page: 1358
  year: 2000
  end-page: 1363
  ident: CR13
  article-title: A sandwich enzyme-linked immunosorbent assay for human serum paraoxonase concentration
  publication-title: J Lipid Res.
– volume: 15
  start-page: 1335
  year: 2001
  end-page: 1349
  ident: CR1
  article-title: Current concepts in the pathogenesis of alcoholic liver injury
  publication-title: FASEB J
  doi: 10.1096/fj.00-0650rev
– volume: 42
  start-page: 91
  year: 2009
  end-page: 98
  ident: CR10
  article-title: The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2008.09.120
– volume: 26
  start-page: 892
  year: 1999
  end-page: 904
  ident: CR18
  article-title: Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants
  publication-title: Free Radic Biol Med
  doi: 10.1016/S0891-5849(98)00272-X
– volume: 28
  start-page: 1335
  year: 2000
  end-page: 1342
  ident: CR8
  article-title: Human serum paraoxonase (PON1) isozymes Q And R hydrolyze lactones and cyclic carbonate esters
  publication-title: Drug Metab Dispos
– volume: 45
  start-page: 51
  year: 2006
  end-page: 59
  ident: CR19
  article-title: Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2005.12.018
– volume: 48
  start-page: 261
  year: 2002
  end-page: 268
  ident: CR4
  article-title: Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage
  publication-title: Clin Chem
– volume: 44
  start-page: 6371
  year: 2005
  end-page: 6382
  ident: CR15
  article-title: Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase
  publication-title: Biochemistry
  doi: 10.1021/bi047440d
– volume: 21
  start-page: 197
  year: 2007
  end-page: 205
  ident: CR16
  article-title: Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds
  publication-title: J Biochem Mol Toxicol
  doi: 10.1002/jbt.20181
– volume: 35
  start-page: 1126
  year: 1983
  end-page: 1138
  ident: CR9
  article-title: The human serum paraoxonase/arylesterase polymorphism
  publication-title: Am J Hum Genet
– volume: 101
  start-page: 1581
  year: 1998
  end-page: 1590
  ident: CR3
  article-title: Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase
  publication-title: J Clin Invest
  doi: 10.1172/JCI1649
– volume: 62
  start-page: 1050
  year: 2008
  end-page: 1055
  ident: CR5
  article-title: Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis
  publication-title: Int J Clin Pract
  doi: 10.1111/j.1742-1241.2006.01206..x
– start-page: 187
  year: 2008
  end-page: 198
  ident: CR7
  publication-title: Paraoxonase-1 in chronic liver diseases, neurological diseases, and HIV infection. The paraoxonases: their role in disease development and xenobiotic metabolism
  doi: 10.1007/978-1-4020-6561-3_12
– volume: 16
  start-page: 79
  year: 2010
  end-page: 83
  ident: CR12
  article-title: Serum paraoxonase activity status in patients with liver disorders
  publication-title: Saudi J Gastroenterol
  doi: 10.4103/1319-3767.61232
– volume: 32
  start-page: 563
  year: 1999
  end-page: 570
  ident: CR11
  article-title: Antioxidants attenuate nuclear factor-Kappa B activation and tumor necrosis factor-alpha production in alcohol hepatitis patient monocytes and rat Kupffer cells, in vitro
  publication-title: Clin Biochem
  doi: 10.1016/S0009-9120(99)00056-9
– start-page: 3
  year: 2008
  end-page: 31
  ident: CR14
  publication-title: Paraoxonases: an historical perspective. The paraoxonases: their role in disease development and xenobiotic metabolism
  doi: 10.1007/978-1-4020-6561-3_1
– volume: 40
  start-page: 645
  year: 2007
  end-page: 650
  ident: CR17
  article-title: Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2007.01.020
– volume: 32
  start-page: 563
  year: 1999
  ident: 334_CR11
  publication-title: Clin Biochem
  doi: 10.1016/S0009-9120(99)00056-9
– volume: 62
  start-page: 1050
  year: 2008
  ident: 334_CR5
  publication-title: Int J Clin Pract
  doi: 10.1111/j.1742-1241.2006.01206..x
– volume: 11
  start-page: 7351
  year: 2005
  ident: 334_CR6
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v11.i46.7351
– volume: 15
  start-page: 1335
  year: 2001
  ident: 334_CR1
  publication-title: FASEB J
  doi: 10.1096/fj.00-0650rev
– volume: 41
  start-page: 1358
  year: 2000
  ident: 334_CR13
  publication-title: J Lipid Res.
  doi: 10.1016/S0022-2275(20)33445-3
– start-page: 3
  volume-title: Paraoxonases: an historical perspective. The paraoxonases: their role in disease development and xenobiotic metabolism
  year: 2008
  ident: 334_CR14
  doi: 10.1007/978-1-4020-6561-3_1
– volume: 40
  start-page: 645
  year: 2007
  ident: 334_CR17
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2007.01.020
– volume: 35
  start-page: 1126
  year: 1983
  ident: 334_CR9
  publication-title: Am J Hum Genet
– volume: 42
  start-page: 91
  year: 2009
  ident: 334_CR10
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2008.09.120
– volume: 45
  start-page: 51
  year: 2006
  ident: 334_CR19
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2005.12.018
– volume: 101
  start-page: 1581
  year: 1998
  ident: 334_CR3
  publication-title: J Clin Invest
  doi: 10.1172/JCI1649
– start-page: 187
  volume-title: Paraoxonase-1 in chronic liver diseases, neurological diseases, and HIV infection. The paraoxonases: their role in disease development and xenobiotic metabolism
  year: 2008
  ident: 334_CR7
  doi: 10.1007/978-1-4020-6561-3_12
– volume: 48
  start-page: 261
  year: 2002
  ident: 334_CR4
  publication-title: Clin Chem
  doi: 10.1093/clinchem/48.2.261
– volume: 26
  start-page: 892
  year: 1999
  ident: 334_CR18
  publication-title: Free Radic Biol Med
  doi: 10.1016/S0891-5849(98)00272-X
– volume: 33
  start-page: 498
  year: 1996
  ident: 334_CR2
  publication-title: Genomics
  doi: 10.1006/geno.1996.0225
– volume: 16
  start-page: 79
  year: 2010
  ident: 334_CR12
  publication-title: Saudi J Gastroenterol
  doi: 10.4103/1319-3767.61232
– volume: 21
  start-page: 197
  year: 2007
  ident: 334_CR16
  publication-title: J Biochem Mol Toxicol
  doi: 10.1002/jbt.20181
– volume: 28
  start-page: 1335
  year: 2000
  ident: 334_CR8
  publication-title: Drug Metab Dispos
  doi: 10.1016/S0090-9556(24)15082-9
– volume: 44
  start-page: 6371
  year: 2005
  ident: 334_CR15
  publication-title: Biochemistry
  doi: 10.1021/bi047440d
– reference: 20339175 - Saudi J Gastroenterol. 2010 Apr-Jun;16(2):79-83
– reference: 18977341 - Clin Biochem. 2009 Jan;42(1-2):91-8
– reference: 9541487 - J Clin Invest. 1998 Apr 15;101(8):1581-90
– reference: 8661009 - Genomics. 1996 May 1;33(3):498-507
– reference: 11805006 - Clin Chem. 2002 Feb;48(2):261-8
– reference: 11387231 - FASEB J. 2001 Jun;15(8):1335-49
– reference: 10614719 - Clin Biochem. 1999 Oct;32(7):563-70
– reference: 16510204 - J Hepatol. 2006 Jul;45(1):51-9
– reference: 6316781 - Am J Hum Genet. 1983 Nov;35(6):1126-38
– reference: 15835926 - Biochemistry. 2005 Apr 26;44(16):6371-82
– reference: 11038162 - Drug Metab Dispos. 2000 Nov;28(11):1335-42
– reference: 10232833 - Free Radic Biol Med. 1999 Apr;26(7-8):892-904
– reference: 17936934 - J Biochem Mol Toxicol. 2007;21(4):197-205
– reference: 16437641 - World J Gastroenterol. 2005 Dec 14;11(46):7351-4
– reference: 10946025 - J Lipid Res. 2000 Aug;41(8):1358-63
– reference: 17887991 - Int J Clin Pract. 2008 Jul;62(7):1050-5
– reference: 17335791 - Clin Biochem. 2007 Jun;40(9-10):645-50
SSID ssj0025493
Score 2.0263832
Snippet Background PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with...
PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 307
SubjectTerms Adolescent
Adult
Aged
Alanine Transaminase - blood
Alkaline Phosphatase - blood
Aryldialkylphosphatase - blood
Aspartate Aminotransferases - blood
Carboxylic Ester Hydrolases - blood
Case-Control Studies
Gastroenterology
Hepatitis B, Chronic - enzymology
Hepatitis, Alcoholic - enzymology
Hepatology
Humans
Medicine
Medicine & Public Health
Middle Aged
Original Article
ROC Curve
Young Adult
Title Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B
URI https://link.springer.com/article/10.1007/s12664-013-0334-1
https://www.ncbi.nlm.nih.gov/pubmed/23700138
https://www.proquest.com/docview/1426006270
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwEA_iQHwRv60fo4JPSqBNk7R7nLI5HfNBHMynkqQpDmYna_fgf-8l_RgyFXwpbUlSuLv0fj_ucofQlQIKQJmSmLJUwyXhWCbMx6knBOUkidKOOTs8euKDMX2csEl1jjuvs93rkKT9U68Ou4EvMRkTAfaCgGKgPC1mqDsY8Zh0G5YFhMeGleEGRxFvQpk_LfHdGa0hzLXoqHU6_V20U6FFt1uqdw9t6GwfbY2qePgBeoatvnx3Z6ZpTgb-yBVZ4orF58zWP7AvlG0PAXzYnWauKBviTpX7pk0qdTHN7ZTV0-0hGvd7L3cDXHVJwCqgtMBMgsMRWqqOJKHiWgmhNRAF6QN4CAHe6QRYSKD9lDAJeEkRTTTAEqU8xXSigiO0mc0zfYJcQCeK-ZJrKn2acICOaZQAiTXqZCkhDvJqccWqKiFuOlnM4lXxYyPhGCQcGwnHvoOumykfZf2MvwZf1jqIwcpN6EJker7MgaCYQvqchJ6DjkvlNMuRILTxVgfd1NqKq42Y__6t03-NPkPbxJqNSS47R5vFYqkvAI0Uso1a3fvXYa8NePxh2La2-AUbDdcL
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS8MwFA6ioL6Id-s1gk9KoE2Ttnuc4pi67UE22FtJ0hQHs5O1e_Dfe5JehkwFX0pbkhTOSXq-j3ND6EYBBWBcScJ4quGSBEQm3COpKwQLaBKlLZM73B8E3RF7HvNxlced19HutUvS_qmXyW5gS0zEhE9c32cEKM8GYIHIxHGNaLthWUB4rFsZbkgUBY0r86clvhujFYS54h21Rqezi3YqtIjbpXr30JrO9tFmv_KHH6BXOOqLdzw1TXMysEdYZAkW88-prX9gXyjbHgL4MJ5kWJQNcScKv2kTSl1Mcjtl-XR_iEadx-FDl1RdEojyGSsIl2BwhJaqJWmoAq2E0BqIgvQAPIQA73QCLMTXXkq5BLykqKYaYIlSruI6Uf4RWs9mmT5BGNCJ4p4MNJMeSwKAjmmUAIk16uQppQ5ya3HFqiohbjpZTONl8WMj4RgkHBsJx56DbpspH2X9jL8GX9c6iGGXG9eFyPRskQNBMYX0Axq6DjouldMsR_3Q-lsddFdrK64OYv77t07_NfoKbXWH_V7cexq8nKFtareQCTQ7R-vFfKEvAJkU8tLuxC-XENdx
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8NAEF6kQvFFvI1nBJ-UpclmN00f61Hq0SJioW9hr2ChpqVNH_z3zm6OIlXBl5CE3Q3MzGa-j5mdQehSAgWgTApMWaLhokIsFPNx4nFOQ6KipGXODvf6YXdAH4dsWPQ5nZfZ7mVIMj_TYKo0pVljqpLG8uAb-BWTPRFgLwgoBvqzDn9j35j1gLQrxgXkx4aY4QZHUViFNX9a4rtjWkGbK5FS64A6W2izQI5uO1f1NlrT6Q6q94rY-C56hW2_-HDHpoFOCr7J5aly-exzbGsh2BfStooAbuyOUpfnzXFH0n3XJq06G83tlOXTzR4adO7fbru46JiAZUBphpkA58O1kC1BmjLUknOtgTQIH4BEE6CeVsBIAu0nhAnATpJoogGiSOlJppUM9lEtnaT6ELmAVCTzRaip8KkKAUYmkQJCa1TLEkIc5JXiimVRTtx0tRjHy0LIRsIxSDg2Eo59B11VU6Z5LY2_Bl-UOojB4k0Yg6d6spgDWTFF9UPS9Bx0kCunWo4ETRt7ddB1qa242JTz37919K_R56j-cteJnx_6T8dog1gLMjlnJ6iWzRb6FEBKJs6sIX4BRkrbrQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+lactonase+and+arylesterase+activities+in+alcoholic+hepatitis+and+hepatitis+B&rft.jtitle=Indian+journal+of+gastroenterology&rft.au=Mogarekar%2C+Mukund+Ramchandra&rft.au=Talekar%2C+Swati+Jitendra&rft.date=2013-09-01&rft.pub=Springer+India&rft.issn=0254-8860&rft.eissn=0975-0711&rft.volume=32&rft.issue=5&rft.spage=307&rft.epage=310&rft_id=info:doi/10.1007%2Fs12664-013-0334-1&rft.externalDocID=10_1007_s12664_013_0334_1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0254-8860&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0254-8860&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0254-8860&client=summon